Application of Immune Checkpoint Inhibitors in the Treatment of Cholangiocarcinoma
Cholangiocarcinoma is a general term for intrahepatic and extrahepatic malignant tumors deriving in the biliary system. According to the location, it is divided into intrahepatic cholangiocarcinoma, hilar cholangiocarcinoma, and distal cholangiocarcinoma. Progressive cholangiocarcinoma yields poor o...
Main Authors: | Fan-li Zeng MD, Jing-fang Chen BD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-09-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/15330338211039952 |
Similar Items
-
Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?
by: María Gutiérrez-Larrañaga, et al.
Published: (2021-09-01) -
Immune Checkpoint Inhibitors in the Treatment of HCC
by: Clelia Donisi, et al.
Published: (2021-01-01) -
Immune Checkpoint Inhibitors in the Treatment of Lymphomas
by: KV Lepik
Published: (2018-10-01) -
Research Progress of Histone Deacetylase Inhibitor Combined with
Immune Checkpoint Inhibitor in the Treatment of Tumor
by: Chen FANG, et al.
Published: (2021-03-01) -
Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment
by: Taylor C. Duke, MD, et al.
Published: (2020-12-01)